Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 30
Encontrada(s) 1 página(s)

Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Differential methylation pattern in pubertal girls associated with biochemical premature adrenarche

  • Ponce, Diana
  • Rodríguez, Fernando
  • Miranda, José Patricio
  • Binder, Alexandra M.
  • Santos Martín, José Luis
  • Michels, Karin B.
  • Cutler, Gordon B.
  • Pereira, Ana
  • Íñiguez, Germán
  • Mericq, Verónica
Biochemical premature adrenarche is defined by elevated serum DHEAS [≥40 μg/dL] before age 8 y in girls. This condition is receiving more attention due to its association with obesity, hyperinsulinemia, dyslipidemia, and polycystic ovary syndrome. Nevertheless, the link between early androgen excess and these risk factors remains unknown. Epigenetic modifications, and specifically DNA methylation, have been associated with the initiation and progression of numerous disorders, including obesity and insulin resistance. The aim of this study was to determine if prepubertal androgen exposure is associated with a different methylation profile in pubertal girls. Eighty-six healthy girls were studied. At age 7 y, anthropometric measurements were begun and DHEAS levels were determined. Girls were classified into Low DHEAS (LD) [<42 μg/dL] and High DHEAS (HD) [≥42 μg/dL] groups. At Tanner stages 2 and 4 a DNA methylation microarray was performed to identify differentially methylated CpG positions (DMPs) between HD and LD groups. We observed a differential methylation pattern between pubertal girls with and without biochemical PA. Moreover, a set of DNA methylation markers, selected by the LASSO method, successfully distinguished between HD and LD girls regardless of Tanner stage. Additionally, a subset of these markers were significantly associated with glucose-related measures such as insulin level, HOMA-IR, and glycaemia. This pilot study provides evidence consistent with the hypothesis that high DHEAS concentration, or its hormonally active metabolites, may induce a unique blood methylation signature in pubertal girls, and that this methylation pattern is associated with altered glucose metabolism., This work was supported by the National Research and Development Agency through the Regular Fondecyt Project N° 1140447 and 1190346 to Dr. Verónica Mericq; the Regular Fondecyt Project N° 1120326 to Dr. Camila Corvalán; and the Regular Fondecyt Project N° 1150416 to José L. Santos and the R01 grant (R01CA158313) to Karin B. Michels.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Case Report: Concurrent de novo pathogenic variants in the LMNA gene as a cause of sporadic partial lipodystrophy

  • Santos Martín, José Luis
  • Miranda, José Patricio
  • Lagos, Carlos F.
  • Cortés, Víctor A.
Introduction: Inherited lipodystrophies are a group of rare diseases defined by severe reduction in adipose tissue mass and classified as generalized or partial. We report a non-familial (sporadic) case of partial lipodystrophy caused by a novel genetic mechanism involving closely linked de novo pathogenic variants in the LMNA gene. Methods: A female adult with partial lipodystrophy and her parents were evaluated for gene variants across the exome under different mendelian inheritance models (autosomal dominant, recessive, compound heterozygous, and X-linked) to find pathogenic variants. Body composition was assessed via dual-energy X-ray absorptiometry (DXA). Results: The patient showed absence of adipose tissue in the limbs; preservation of adiposity in the face, neck, and trunk; muscular hypertrophy, hypertriglyceridemia and insulin resistance. DXA revealed a fat mass of 15.4%, with android-to-gynoid ratio, trunk/limb, and trunk/leg ratios exceeding the published upper limits of 90% reference intervals. Two heterozygous missense de novo pathogenic variants in cis within the LMNA gene were found in the proband: p.Y481H and p.K486N (NP_733821.1). These variants have functional effects and were reported in inherited Emery-Dreifuss muscular dystrophy 2 (p.Y481H) and familial partial lipodystrophy type 2 (p.K486N). Molecular modeling analyses provided additional insights into the protein instability conferred by these variants in the lamin A/C Ig-like domain. Conclusion: In a case of sporadic partial lipodystrophy, we describe two concurrent de novo pathogenic variants within the same gene (LMNA) as a novel pathogenic mechanism. This finding expands the genetic and phenotypic spectrum of partial lipodystrophy and laminopathy syndromes., The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research is supported by FONDECYT 1221146, Anillo ACT210039 and Fondequip EQM230130 to VC. JLS acknowledges the support from FONDECYT 1150416. CFL acknowledges support from Centro Basal Ciencia and Vida, FB210008/ANID. Powered@NLHPC: This research was partially supported by the supercomputing infrastructure of the NLHPC (CCSS210001). Genotyping of Chilean ECO participants for allele frequencies was performed at the Spanish National Cancer Research Centre in the Human Genotyping lab, a member of CeGen, PRB3, and supported by grant PT17/0019, of the PE I + D + i 2013–2016, funded by ISCIII and ERDF.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Increased C-X-C motif chemokine ligand 12 levels in cerebrospinal fluid as a candidate biomarker in sporadic amyotrophic lateral sclerosis

  • Andrés Benito, Pol
  • Povedano, Mónica
  • Domínguez Rubio, Raúl
  • Marco, Carla
  • Colomina, María J.
  • López-Pérez, Óscar
  • Santana, Isabel
  • Baldeiras, Inês
  • Martínez-Yelámos, Sergio
  • Zerr, Inga
  • Llorens, Franc
  • Fernández Irigoyen, Joaquín
  • Santamaría Martínez, Enrique
  • Ferrer, Isidro
Sporadic amyotrophic lateral sclerosis (sALS) is a fatal progressive neurodegenerative disease affecting upper and lower motor neurons. Biomarkers are useful to facilitate the diagnosis and/or prognosis of patients and to reveal possible mechanistic clues about the disease. This study aimed to identify and validate selected putative biomarkers in the cerebrospinal fluid (CSF) of sALS patients at early disease stages compared with age-matched controls and with other neurodegenerative diseases including Alzheimer disease (AD), spinal muscular atrophy type III (SMA), frontotemporal dementia behavioral variant (FTD), and multiple sclerosis (MS). SWATH acquisition on liquid chromatography-tandem mass spectrometry (LC–MS/MS) for protein quantitation, and ELISA for validation, were used in CSF samples of sALS cases at early stages of the disease. Analysis of mRNA and protein expression was carried out in the anterior horn of the lumbar spinal cord in post-mortem tissue of sALS cases (terminal stage) and controls using RTq-PCR, and Western blotting, and immunohistochemistry, respectively. SWATH acquisition on liquid chromatography-tandem mass spectrometry (LC–MS/MS) revealed 51 differentially expressed proteins in the CSF in sALS. Receiver operating characteristic (ROC) curves showed CXCL12 to be the most valuable candidate biomarker. We validated the values of CXCL12 in CSF with ELISA in two different cohorts. Besides sALS, increased CXCL12 levels were found in MS but were not altered in AD, SMA, and FTD. Therefore, increased CXCL12 levels in the CSF can be useful in the diagnoses of MS and sALS in the context of the clinical settings. CXCL12 immunoreactivity was localized in motor neurons in control and sALS, and in a few glial cells in sALS at the terminal stage; CXCR4 was in a subset of oligodendroglial-like cells and axonal ballooning of motor neurons in sALS; and CXCR7 in motor neurons in control and sALS, and reactive astrocytes in the pyramidal tracts in terminal sALS. CXCL12/CXCR4/CXCR7 axis in the spinal cord probably plays a complex role in inflammation, oligodendroglial and astrocyte signaling, and neuronal and axonal preservation in sALS., The project leading to these results received funding from Fundació Miquel Valls, 'Retos todos unidos contra la ELA' and 'Proyecto DGeneracion conexiones con sentido' to MP. The study was also supported by the Ministry of Economy and Competitiveness, Institute of Health Carlos III (ISCIII) (co-funded by European RegiSonal Development Fund, ERDF, a way to build Europe): FISPI17/000809 to IF; and FIS (ISCIII) grant PI19/00144 to FLl. The Proteomics Unit of Navarrabiomed is supported by grant PT17/0019/009 to JFI, of the PE I+D+I 2013-2016 funded by ISCIII and FEDER. Part of this work was funded by a grant from the Spanish Ministry of Science Innovation and Universities (Ref. PID2019-110356RB-I00) to JFI and ES.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides

  • Gualdrón-López, Melisa
  • Ayllon-Hermida, Alberto
  • Cortes-Serra, Núria
  • Resa-Infante, Patricia
  • Bech-Serra, Joan Josep
  • Aparici-Herraiz, Iris
  • Nicolau-Fernandez, Marc
  • Erkizia, Itziar
  • Gutierrez-Chamorro, Lucia
  • Marfil, Silvia
  • Pradenas, Edwards
  • Ávila Nieto, Carlos
  • Cucurull, Bernat
  • Montaner-Tarbés, Sergio
  • Muelas, Magdalena
  • Sotil, Ruth
  • Ballana, Ester
  • Urrea, Victor
  • Fraile, Lorenzo
  • Montoya, Maria
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • Carrillo, Jorge
  • Izquierdo-Useros, Nuria
  • Blanco, Julià
  • Fernandez-Becerra, Carmen
  • de La Torre, Carolina
  • Pinazo, Maria-Jesus
  • Martinez-Picado, Javier
  • del Portillo, Hernando A.
Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine development. Furthermore, plasma-derived EVs may elucidate pathological changes occurring in distal tissues during viral infections. We hypothesized that molecular characterization of EVs isolated from COVID-19 patients would reveal peptides suitable for vaccine development. Blood samples were collected from three cohorts: severe COVID-19 patients (G1), mild/asymptomatic cases (G2), and SARS-CoV-2-negative healthcare workers (G3). Samples were obtained at two time points: during the initial phase of the pandemic in early 2020 (m0) and eight months later (m8). Clinical data analysis revealed elevated inflammatory markers in G1. Notably, non-vaccinated individuals in G1 exhibited increased levels of neutralizing antibodies at m8, suggesting prolonged exposure to viral antigens. Proteomic profiling of EVs was performed using three distinct methods: immunocapture (targeting CD9), ganglioside-capture (utilizing Siglec-1) and size-exclusion chromatography (SEC). Contrary to our hypothesis, this analysis failed to identify viral peptides. These findings were subsequently validated through Western blot analysis targeting the RBD of the SARS-CoV-2 Spike protein’s and comparative studies using samples from experimentally infected Syrian hamsters. Furthermore, analysis of the EV cargo revealed a diverse molecular profile, including components involved in the regulation of viral replication, systemic inflammation, antigen presentation, and stress responses. These findings underscore the potential significance of EVs in the pathogenesis and progression of COVID-19., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The proteomics of EVs isolated by CD9 was performed at the proteomics facility of Utrecht (Netherlands) as part of an EPIC-XS grant (0000205) to CT and HP. The proteomics analyses of EVs isolated by SEC were performed in the IJC Proteomic unit, which is part of the of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and ERDF”. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech), and it is supported by “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595). We thank Foundation Dormeur for financial support for the acquisition of the QuantStudio-5 real time PCR system. JM-P was supported by the Spanish Ministry of Science,Innovation and Universities (grants PID2022-139271OB-I00 and CB21/13/00063, Spain), and Fundació La Marató de TV3 (grant 202120-30-31-32, Spain). Funded in part by the European Union. The PCR-4-ALL and UNDINE projects have received funding under the Horizon Europe research and innovation programme (grant agreement No 101095606 and No 101057100 respectively). CF-B and HP acknowledge support from the Spanish Ministry of Science and Innovation (MICINN) (PID2022- 142908OB-I00) and support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. This research is part of the ISGlobal’s Program on the Molecular Mechanisms of Malaria which is partially supported by the Fundación Ramón Areces. We also acknowledged the internal funding from IrsiCaixa through the crowdfunding initiative YoMeCorono (JM-P) and ISGlobal (HP) to initiate these studies., info:eu-repo/semantics/publishedVersion
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Integrative metabolic pathway analysis reveals novel therapeutic targets in osteoarthritis

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Eijkel, Gert
  • Calamia, Valentina
  • Fernández-Puente, Patricia
  • Paine, Martin R.L.
  • Ruiz-Romero, Cristina
  • Heeren, Ron M.A.
  • Blanco García, Francisco J
Data availability: The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (https://www.ebi.ac.uk/pride/archive/projects/PXD012879) with the dataset identifier PXD012879 and the project name of MSCs OA SILAC Mass spectrometry imaging, [Abstract] In osteoarthritis (OA), impairment of cartilage regeneration can be related to a defective chondrogenic differentiation of mesenchymal stromal cells (MSCs). Therefore, understanding the proteomic- and metabolomic-associated molecular events during the chondrogenesis of MSCs could provide alternative targets for therapeutic intervention. Here, a SILAC-based proteomic analysis identified 43 proteins related with metabolic pathways whose abundance was significantly altered during the chondrogenesis of OA human bone marrow MSCs (hBMSCs). Then, the level and distribution of metabolites was analyzed in these cells and healthy controls by matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI), leading to the recognition of characteristic metabolomic profiles at the early stages of differentiation. Finally, integrative pathway analysis showed that UDP-glucuronic acid synthesis and amino sugar metabolism were downregulated in OA hBMSCs during chondrogenesis compared with healthy cells. Alterations in these metabolic pathways may disturb the production of hyaluronic acid (HA) and other relevant cartilage extracellular matrix (ECM) components. This work provides a novel integrative insight into the molecular alterations of osteoarthritic MSCs and potential therapeutic targets for OA drug development through the enhancement of chondrogenesis., This work has been funded by Fondo Investigación Sanitaria-Spain (grant numbers PI14/01707, PI16/02124, PI17/00404, DTS17/00200, CIBER-CB06/01/0040 and RETIC-RIER-RD12/0009/0018), a part of the National Plan for Scientific Program Development and Technological Innovation 2013–2016, funded by the ISCIII-General Subdirection of Assessment and Promotion of Research - European Regional Development Fund (FEDER) “A way of making Europe.” The Proteomics Unit of GIR belongs to ProteoRed, PRB2- ISCIII (grant number PT17/0019/0014). B.R. is supported by Xunta de Galicia (IN606B-2016/004). The research was partially performed within the M4I research program, financially supported by the Dutch Province of Limburg as part of the “LINK” program, Xunta de Galicia; IN606B-2016/004, https://www.ebi.ac.uk/pride/archive/projects/PXD012879
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Targeted phospholipidomic analysis of synovial fluid as a tool for osteoarthritis deep phenotyping

  • Rocha Loureda, Beatriz
  • Illiano, Anna
  • Calamia, Valentina
  • Pinto, Gabriella
  • Amoresano, Angela
  • Ruiz-Romero, Cristina
  • Blanco García, Francisco J
[Abstract] Objective. The aim of this study was to carry out a targeted phospholipidomic analysis on synovial fluid (SF) from patients with different grades of osteoarthritis (OA) and controls, in order to search for specific phospholipid profiles that may be useful for the deep phenotyping of this disease. Design. Multiple reaction monitoring-mass spectrometry (MRM/MS) was applied to explore the potential phospholipidomic differences in the SF of knee OA patients (n ​= ​15) (subclassified into early- and late-stage OA) and non-OA controls (n ​= ​4). Multivariate statistical analyses conducted by partial least squares discriminant analysis (PLS-DA) and hierarchical clustering analysis (HCA) were performed to identify significantly altered phospholipids in OA, characterize phospholipidomic profiles associated with the radiographic stage of the disease and describe potential endotypes at early stages. Results. Significant discrimination of phospholipid profiles between non-OA controls and the early- and late-stage OA groups were found by PLS-DA and HCA. Compared to SF from non-OA controls, OA patients showed higher levels of most quantified phospholipid species, including phosphatidylcholines (PC), phosphatidylserines and phosphatidylinositols. Furthermore, several PC species showed significant differences in abundance between the two OA subgroups and were negatively correlated with cartilage damage. Finally, two distinct endotypes of early-stage OA were identified based on the phospholipidomic profile of SF. Conclusions. Our data provides a novel insight into the phospholipid profiles of OA synovial fluid, revealing specific alterations associated with the radiographic stage of the disease. This targeted phospholipidomic profiling also facilitated the characterization of two different OA endotypes at early stages of the disease., This work is supported by grants from Fondo Investigación Sanitaria-Spain (PI16/02124, PI17/00404, PI19/01206, PI20/00793 and RETIC-RIER-RD16/0012/0002), integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research - European Regional Development Fund (FEDER) “A way of making Europe”. This study is also supported by AE CICA-INIBIC (ED431E 2018/03) and grants IN607A 2017/11, IN607A 2021/7 and IN607D 2020/10 from Axencia Galega de Innovacion - Xunta de Galicia. The Biomedical Research Networking Center (CIBER) is an initiative from Instituto de Salud Carlos III (ISCIII). The Proteomics Unit of GIR belongs to ProteoRed, PRB3- ISCIII (PT17/0019/0014), Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN607A 2017/11, Xunta de Galicia; IN607A 2021/7, Xunta de Galicia; IN607D 2020/10
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

Identification of a distinct lipidomic profile in the osteoarthritic synovial membrane by mass spectrometry imaging

  • Rocha Loureda, Beatriz
  • Cillero-Pastor, B.
  • Ruiz-Romero, Cristina
  • Paine, Martin R.L.
  • Cañete, Juan D.
  • Heeren, Ron M.A.
  • Blanco García, Francisco J
[Abstract] Objective: Synovial inflammation is one of the most characteristic events in different types of arthritis, including Osteoarthritis (OA). Emerging evidence also suggests the involvement of lipids in the regulation of inflammatory processes. The aim of this study was to elucidate the heterogeneity and spatial distribution of lipids in the OA synovial membrane and explore their putative involvement in inflammation. Method: The abundance and distribution of lipids were examined in human synovial membranes. To this end, histological cuts from this tissue were analysed by matrix-assisted laser desorption ionization - mass spectrometry imaging (MALDI-MSI). The lipidomic profile of OA synovium was characterized and compared with healthy and other forms of inflammatory arthropathies as Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) using principal component analysis and discriminant analysis methods. Lipid identification was undertaken by tandem MS analyses and database queries. Results: Our results reveal differential and characteristic lipidomic profiles between OA and control samples. Specifically, we unveiled that OA synovium presents elevated levels of phosphatidylcholines, fatty acids and lysophosphatidic acids and lower levels of lysophosphatidylcholines compared to control tissues. The spatial distribution of particular glycerophospholipids was also correlated with hypertrophic, inflamed or vascularized synovial areas. Compared with other inflammatory arthritis, the OA tissue showed lower amounts of phosphatidylethanolamine-based plasmalogens. Conclusions: This study provides a novel insight into the lipid profiles of synovial membrane and differences in abundance between OA and control tissues. The lipidomic alterations improves understanding of the pathogenic mechanisms of OA and may be important for its diagnosis., This work is supported by grants from Fondo Investigación Sanitaria-Spain (PI16/02124, PI17/00404 PI19/01206 and RETIC-RIER-RD16/0012/0002), integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research – European Regional Development Fund (FEDER) “A way of making Europe”. This study is also supported by AE CICA-INIBIC (ED431E 2018/03) and grants IN607A2017/11 and IN607D2020/10 from Xunta de Galicia. The Biomedical Research Networking Center (CIBER) is an initiative from Instituto de Salud Carlos III (ISCIII). The Proteomics Unit of GIR belongs to ProteoRed, PRB3- ISCIII (PT17/0019/0014). B.R. has been supported by Xunta de Galicia (IN606B-2016/004). The research was partially performed within the M4I research program, financially supported by the Dutch Province of Limburg as part of the “LINK” program, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN607A2017/11, Xunta de Galicia; IN607D2020/10, Xunta de Galicia; IN606B-2016/004
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

mtDNA haplogroup A enhances the effect of obesity on the risk of knee OA in a mexican population

  • Ramos-Louro, Paula
  • Arellano Pérez Vertti, Rubén Daniel
  • López-Reyes, Alberto
  • Martínez-Nava, Gabriela Angélica
  • Espinosa, Rolando
  • Pineda, Carlos
  • González Galarza, Faviel Francisco
  • Argüello Astorga, Rafael
  • Aguilar Muñiz, Lizette Sarai
  • Hernández Terán, Fernando
  • Parra Torres, Nancy Marbella
  • Durán-Sotuela, Alejandro
  • Fernández-Moreno, Mercedes
  • Balboa-Barreiro, Vanesa
  • Blanco García, Francisco J
  • Rego-Pérez, I.
[Abstract] To evaluate the influence of mitochondrial DNA haplogroups on the risk of knee OA in terms of their interaction with obesity, in a population from Mexico. Samples were obtained from (n = 353) knee OA patients (KL grade ≥ I) and (n = 364) healthy controls (KL grade = 0) from Mexico city and Torreon (Mexico). Both Caucasian and Amerindian mtDNA haplogroups were assigned by single base extension assay. A set of clinical and demographic variables, including obesity status, were considered to perform appropriate statistical approaches, including chi-square contingency tables, regression models and interaction analyses. To ensure the robustness of the predictive model, a statistical cross-validation strategy of B = 1000 iterations was used. All the analyses were performed using boot, GmAMisc and epiR package from R software v4.0.2 and SPSS software v24. The frequency distribution of the mtDNA haplogroups between OA patients and healthy controls for obese and non-obese groups showed the haplogroup A as significantly over-represented in knee OA patients within the obese group (OR 2.23; 95% CI 1.22-4.05; p-value = 0.008). The subsequent logistic regression analysis, including as covariate the interaction between obesity and mtDNA haplogroup A, supported the significant association of this interaction (OR 2.57; 95% CI 1.24-5.32; p-value = 0.011). The statistical cross-validation strategy confirmed the robustness of the regression model. The data presented here indicate a link between obesity in knee OA patients and mtDNA haplogroup A., This work is supported by Grants from Fondo de Investigación Sanitaria (PI17/00210, PI16/02124, PI20/00614, RETIC-RIER-RD16/0012/0002 and PRB3-ISCIII-PT17/0019/0014) integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) “A way of making Europe” and Grant IN607A2017/11 from Xunta de Galicia. The authors further acknowledge AE CICA-INIBIC (ED431E 2018/03) for financial support. IRP is supported by Contrato Miguel Servet-II Fondo de Investigación Sanitaria (CPII17/00026) and AD-S is supported by Grant IN606A-2018/023 from Xunta de Galicia, Spain. The Biomedical Research Networking Center (CIBER) is an initiative from Instituto de Salud Carlos III (ISCIII), Xunta de Galicia; IN607A2017/11, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN606A-2018/023
RUC. Repositorio da Universidade da Coruña
Publicación Artículo científico (JournalArticle)

A clinical model including protein biomarkers predicts radiographic knee osteoarthritis: a prospective study using data from the Osteoarthritis Initiative

  • Lourido Salas, Lucía María
  • Balboa-Barreiro, Vanesa
  • Ruiz-Romero, Cristina
  • Rego-Pérez, I.
  • Camacho Encina, María
  • Paz González, Rocío
  • Calamia, Valentina
  • Oreiro Villar, Natividad
  • Nilsson, Peter
  • Blanco García, Francisco J
The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Pfizer, Inc.; Novartis Pharmaceuticals Corporation; Merck Research Laboratories; and GlaxoSmithKline. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This work has been supported by grants from Fondo Investigación Sanitaria (PI16/02124, PI17/00404, PI19/01206, DTS17/00200, CIBER-CB06/01/0040 and RETIC-RIER-RD16/0012/0002), integrated in the National Plan for Scientific Program, Development and Technological Innovation 2013–2016 and funded by the ISCIII-General Subdirection of Assessment and Promotion of Research-European Regional Development Fund (FEDER) “A way of making Europe”. This study has been also supported by grants IN607A2017/11, IN607D2020/10 and AE CICA-INIBIC (ED431E 2018/03) from Xunta de Galicia. The Proteomics Unit of GIR belongs to ProteoRed, PRB3- ISCIII (PT17/0019/0014). L.L. is supported by Xunta de Galicia (IN606B-2016/2005) and Contrato Sara Borrell (CD19/00229) Fondo de Investigación Sanitaria, ISCIII. I.R.P. is supported by Contrato Miguel Servet-II Fondo de Investigación Sanitaria (CPII17/00026). This work was also supported by the KTH Center for Applied Precision Medicine funded by the Ehrling Persson foundation, as well as the Human Protein Atlas project funded by Knut and Alice Wallenberg Foundation, Xunta de Galicia; IN607A2017/11, Xunta de Galicia; IN607D2020/10, Xunta de Galicia; ED431E 2018/03, Xunta de Galicia; IN606B-2016/2005
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

The outer-membrane protein MafA of Neisseria meningitidis constitutes a novel protein secretion pathway specific for the fratricide protein MafB

  • Arenas, J.
  • Catón, L.
  • van den Hoeven, T.
  • de Maat, V.
  • Cruz Herrero, J.
  • Tommassen, J.
MafB proteins are toxins secreted by Neisseria spp. which are involved in interbacterial competition. Their secretion mechanism has so far not been elucidated. Each strain can produce several MafB variants. On the chromosome, the mafB genes are localized on genomic islands also containing mafA genes. MafA proteins have a role in virulence with reported activities in adhesion and transcytosis of pathogenic Neisseria, a priori unrelated to MafB activities. In this study, we investigated the possible involvement of MafA in the transport of MafB across the outer membrane of Neisseria meningitidis. In wild-type strains, proteolytic fragments of MafB proteins were detected in the extracellular medium. In the absence of MafA, secretion was abrogated, and, in the case of MafBI, full-length and truncated polypeptides were detected inside the cells and inside outer-membrane vesicles. MafBI secretion required its cognate MafA, whereas MafBIII could use any MafA. Heterologous expression in Escherichia coli showed that MafBIII is transported to a cell-surface-exposed, i.e. protease-accessible, location in a MafA-dependent way. MafA itself was found to be localized to the outer membrane, forming large oligomeric complexes. As homologs were found in diverse bacteria, the Maf system represents a new protein secretion system in Gram-negative bacteria.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Comprehensive and systematic characterization of multi-functionalized cisplatin nano-conjugate: from the chemistry and proteomic biocompatibility to the animal model

  • Hernández, Ángela-Patricia
  • Micaelo, Ania
  • Piñol, Rafael
  • García-Vaquero, Marina L.
  • Aramayona, José J.
  • Criado, Julio J.
  • Rodriguez, Emilio
  • Sánchez-Gallego, José Ignacio
  • Landeira-Viñuela, Alicia
  • Juanes-Velasco, Pablo
  • Díez, Paula
  • Góngora, Rafael
  • Jara-Acevedo, Ricardo
  • Orfao, Alberto
  • Miana-Mena, Javier
  • Muñoz, María Jesús
  • Villanueva, Sergio
  • Millán, Ángel
  • Fuentes, Manuel
Background Nowadays, nanoparticles (NPs) have evolved as multifunctional systems combining different custom anchorages which opens a wide range of applications in biomedical research. Thus, their pharmacological involvements require more comprehensive analysis and novel nanodrugs should be characterized by both chemically and biological point of view. Within the wide variety of biocompatible nanosystems, iron oxide nanoparticles (IONPs) present mostly of the required features which make them suitable for multifunctional NPs with many biopharmaceutical applications. Results Cisplatin-IONPs and different functionalization stages have been broadly evaluated. The potential application of these nanodrugs in onco-therapies has been assessed by studying in vitro biocompatibility (interactions with environment) by proteomics characterization the determination of protein corona in different proximal fluids (human plasma, rabbit plasma and fetal bovine serum),. Moreover, protein labeling and LC–MS/MS analysis provided more than 4000 proteins de novo synthetized as consequence of the nanodrugs presence defending cell signaling in different tumor cell types (data available via ProteomeXchanges with identified PXD026615). Further in vivo studies have provided a more integrative view of the biopharmaceutical perspectives of IONPs. Conclusions Pharmacological proteomic profile different behavior between species and different affinity of protein coating layers (soft and hard corona). Also, intracellular signaling exposed differences between tumor cell lines studied. First approaches in animal model reveal the potential of theses NPs as drug delivery vehicles and confirm cisplatin compounds as strengthened antitumoral agents.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Enhancement of tumor cell immunogenicity and antitumor properties derived from platinum-conjugated iron nanoparticles

  • Hernández, Ángela-Patricia
  • Iglesias-Anciones, Laura
  • Vaquero-González, José Javier
  • Piñol, Rafael
  • Criado, Julio J.
  • Rodriguez, Emilio
  • Juanes-Velasco, Pablo
  • García-Vaquero, Marina L.
  • Arias-Hidalgo, Carlota
  • Orfao, Alberto
  • Millán, Ángel
  • Fuentes, Manuel
From chemistry design to clinical application, several approaches have been developed to overcome platinum drawbacks in antitumoral therapies. An in-depth understanding of intracellular signaling may hold the key to the relationship of both conventional drugs and nanoparticles. Within these strategies, first, nanotechnology has become an essential tool in oncotherapy, improving biopharmaceutical properties and providing new immunomodulatory profiles to conventional drugs mediated by activation of endoplasmic reticulum (ER) stress. Secondly, functional proteomics techniques based on microarrays have proven to be a successful method for high throughput screening of proteins and profiling of biomolecule mechanisms of action. Here, we conducted a systematic characterization of the antitumor profile of a platinum compound conjugated with iron oxide nanoparticles (IONPs). As a result of the nano-conjugation, cytotoxic and proteomics profiles revealed a significant improvement in the antitumor properties of the starting material, providing selectivity in certain tumor cell lines tested. Moreover, cell death patterns associated with immunogenic cell death (ICD) response have also been identified when ER signaling pathways have been triggered. The evaluation in several tumor cell lines and the analysis by functional proteomics techniques have shown novel perspectives on the design of new cisplatin-derived conjugates, the high value of IONPs as drug delivery systems and ICD as a rewarding approach for targeted oncotherapy and onco-immunotherapies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Endoplasmic Reticulum Protein TXNDC5 Interacts with PRDX6 and HSPA9 to Regulate Glutathione Metabolism and Lipid Peroxidation in the Hepatic AML12 Cell Line

  • Bidooki, Seyed Hesamoddin
  • Sánchez-Marco, Javier
  • Martínez-Beamonte, Roberto
  • Herrero-Continente, Tania
  • Navarro, María A.
  • Rodríguez-Yoldi, María J.
  • Osada, Jesús
Non-alcoholic fatty liver disease or steatosis is an accumulation of fat in the liver. Increased amounts of non-esterified fatty acids, calcium deficiency, or insulin resistance may disturb endoplasmic reticulum (ER) homeostasis, which leads to the abnormal accumulation of misfolded proteins, activating the unfolded protein response. The ER is the primary location site for chaperones like thioredoxin domain-containing 5 (TXNDC5). Glutathione participates in cellular oxidative stress, and its interaction with TXNDC5 in the ER may decrease the disulfide bonds of this protein. In addition, glutathione is utilized by glutathione peroxidases to inactivate oxidized lipids. To characterize proteins interacting with TXNDC5, immunoprecipitation and liquid chromatography–mass spectrometry were used. Lipid peroxidation, reduced glutathione, inducible phospholipase A2 (iPLA2) and hepatic transcriptome were assessed in the AML12 and TXNDC5-deficient AML12 cell lines. The results showed that HSPA9 and PRDX6 interact with TXNDC5 in AML12 cells. In addition, TXNDC5 deficiency reduced the protein levels of PRDX6 and HSPA9 in AML12. Moreover, lipid peroxidation, glutathione and iPLA2 activities were significantly decreased in TXNDC5-deficient cells, and to find the cause of the PRDX6 protein reduction, proteasome suppression revealed no considerable effect on it. Finally, hepatic transcripts connected to PRDX6 and HSPA9 indicated an increase in the Dnaja3, Mfn2 and Prdx5 and a decrease in Npm1, Oplah, Gstp3, Gstm6, Gstt1, Serpina1a, Serpina1b, Serpina3m, Hsp90aa1 and Rps14 mRNA levels in AML12 KO cells. In conclusion, the lipid peroxidation system and glutathione mechanism in AML12 cells may be disrupted by the absence of TXNDC5, a novel protein–protein interacting partner of PRDX6 and HSPA9.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

ATAD3C regulates ATAD3A assembly and function in the mitochondrial membrane

  • Gaudó, Paula
  • de Tomás-Mateo, Elena
  • Garrido-Pérez, Nuria
  • Santana, Alfredo
  • Ruiz-Pesini, Eduardo
  • Montoya, Julio
  • Bayona-Bafaluy, Pilar
Mitochondrial ATAD3A is an ATPase Associated with diverse cellular Activities (AAA) domain containing enzyme, involved in the structural organization of the inner mitochondrial membrane and of increasing importance in childhood disease. In humans, two ATAD3A paralogs arose by gene duplication during evolution: ATAD3B and ATAD3C. Here we investigate the cellular activities of the ATAD3C paralog that has been considered a pseudogene. We detected unique ATAD3C peptides in HEK 293T cells, with expression similar to that in human tissues, and showed that it is an integral membrane protein that exposes its carboxy-terminus to the intermembrane space. Overexpression of ATAD3C, but not of ATAD3A, in fibroblasts caused a decrease in cell proliferation and oxygen consumption rate, and an increase of cellular ROS. This was due to the incorporation of ATAD3C monomers in ATAD3A complex in the mitochondrial membrane reducing its size. Consistent with a negative regulation of ATAD3A function in mitochondrial membrane organization, ATAD3C expression led to increased accumulation of respiratory chain dimeric CIII in the inner membrane, to the detriment to that assembled in respiratory supercomplexes. Our results demonstrate a negative dominant role of the ATAD3C paralog with implications for mitochondrial OXPHOS function and suggest that its expression regulates ATAD3A in the cell.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer

  • Gargallo-Puyuelo, C.J.
  • Lanas, Á.
  • Carrera-Lasfuentes, P.
  • Ferrández, Á.
  • Quintero, E.
  • Carrillo, M.
  • Alonso-Abreu, I.
  • García-González, M.A.
INTRODUCTION: Epidemiological studies estimate that having a first-degree relative (FDR) with colorectal cancer (CRC) increases 2-fold to 3-fold the risk of developing the disease. Because FDRs of CRC patients are more likely to co-inherit CRC risk variants, we aimed to evaluate potential differences in genotype distribution of single nucleotide polymorphisms (SNPs) related to CRC risk between FDRs of patients with nonsyndromic CRC (cases) and individuals with no family history of CRC (controls). METHODS: We designed a case-control study comprising 750 cases and 750 Spanish Caucasian controls matched by sex, age, and histological findings after colonoscopy. Genomic DNA from all participants was genotyped for 88 SNPs associated with CRC risk using the MassArray (Sequenom) platform. RESULTS: Ten of the 88 SNPs analyzed revealed significant associations (P < 0.05) with a family history of CRC in our population. The most robust associations were found for the rs17094983G>A SNP in the long noncoding RNA LINC01500 (odds ratio = 0.72; 95% confidence interval: 0.58-0.88, log-additive model), and the rs11255841T>A SNP in the long noncoding RNA LINC00709 (odds ratio = 2.04; 95% confidence interval: 1.19-3.51, dominant model). Of interest, the observed associations were in the same direction than those reported for CRC risk. DISCUSSION: FDRs of CRC patients show significant differences in genotype distribution of SNPs related to CRC risk as compared to individuals with no family history of CRC. Genotyping of CRC risk variants in FDRs of CRC patients may help to identify subjects at risk that would benefit from stricter surveillance and CRC screening programs.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Proteomics of circulating extracellular vesicles reveals diverse clinical presentations of COVID-19 but fails to identify viral peptides

  • Gualdrón-López, Melisa
  • Ayllon-Hermida, Alberto
  • Cortes-Serra, Núria
  • Resa-Infante, Patricia
  • Bech-Serra, Joan Josep
  • Aparici-Herraiz, Iris
  • Nicolau-Fernandez, Marc
  • Erkizia, Itziar
  • Gutierrez-Chamorro, Lucia
  • Marfil, Silvia
  • Pradenas, Edwards
  • Ávila Nieto, Carlos
  • Cucurull, Bernat
  • Montaner-Tarbés, Sergio
  • Muelas, Magdalena
  • Sotil, Ruth
  • Ballana, Ester
  • Urrea, Victor
  • Fraile, Lorenzo
  • Montoya, Maria
  • Vergara-Alert, Júlia
  • Segalés, Joaquim
  • Carrillo, Jorge
  • Izquierdo-Useros, Nuria
  • Blanco, Julià
  • Fernandez-Becerra, Carmen
  • de La Torre, Carolina
  • Pinazo, Maria-Jesus
  • Martinez-Picado, Javier
  • del Portillo, Hernando A.
Extracellular vesicles (EVs) released by virus-infected cells have the potential to encapsulate viral peptides, a characteristic that could facilitate vaccine development. Furthermore, plasma-derived EVs may elucidate pathological changes occurring in distal tissues during viral infections. We hypothesized that molecular characterization of EVs isolated from COVID-19 patients would reveal peptides suitable for vaccine development. Blood samples were collected from three cohorts: severe COVID-19 patients (G1), mild/asymptomatic cases (G2), and SARS-CoV-2-negative healthcare workers (G3). Samples were obtained at two time points: during the initial phase of the pandemic in early 2020 (m0) and eight months later (m8). Clinical data analysis revealed elevated inflammatory markers in G1. Notably, non-vaccinated individuals in G1 exhibited increased levels of neutralizing antibodies at m8, suggesting prolonged exposure to viral antigens. Proteomic profiling of EVs was performed using three distinct methods: immunocapture (targeting CD9), ganglioside-capture (utilizing Siglec-1) and size-exclusion chromatography (SEC). Contrary to our hypothesis, this analysis failed to identify viral peptides. These findings were subsequently validated through Western blot analysis targeting the RBD of the SARS-CoV-2 Spike protein’s and comparative studies using samples from experimentally infected Syrian hamsters. Furthermore, analysis of the EV cargo revealed a diverse molecular profile, including components involved in the regulation of viral replication, systemic inflammation, antigen presentation, and stress responses. These findings underscore the potential significance of EVs in the pathogenesis and progression of COVID-19., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The proteomics of EVs isolated by CD9 was performed at the proteomics facility of Utrecht (Netherlands) as part of an EPIC-XS grant (0000205) to CT and HP. The proteomics analyses of EVs isolated by SEC were performed in the IJC Proteomic unit, which is part of the of Proteored, PRB3 and is supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and ERDF”. The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech), and it is supported by “Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya” (2017SGR595). We thank Foundation Dormeur for financial support for the acquisition of the QuantStudio-5 real time PCR system. JM-P was supported by the Spanish Ministry of Science,Innovation and Universities (grants PID2022-139271OB-I00 and CB21/13/00063, Spain), and Fundació La Marató de TV3 (grant 202120-30-31-32, Spain). Funded in part by the European Union. The PCR-4-ALL and UNDINE projects have received funding under the Horizon Europe research and innovation programme (grant agreement No 101095606 and No 101057100 respectively). CF-B and HP acknowledge support from the Spanish Ministry of Science and Innovation (MICINN) (PID2022- 142908OB-I00) and support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. This research is part of the ISGlobal’s Program on the Molecular Mechanisms of Malaria which is partially supported by the Fundación Ramón Areces. We also acknowledged the internal funding from IrsiCaixa through the crowdfunding initiative YoMeCorono (JM-P) and ISGlobal (HP) to initiate these studies., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer's disease cerebrospinal fluid

  • Lleó, Alberto|||0000-0002-2568-5478
  • Núñez-Llaves, Raúl|||0000-0002-6702-4774
  • Alcolea, Daniel|||0000-0002-3819-3245
  • Chiva, Cristina
  • Balateu Paños, Daniel
  • Colom-Cadena, Martí|||0000-0002-8514-4534
  • Gómez, Gemma
  • Muñoz, Laia|||0000-0003-0578-3094
  • Querol-Vilaseca, Marta|||0000-0002-8589-1636
  • Pegueroles, Jordi|||0000-0002-3554-2446
  • Rami Gonzalez, Lorena|||0000-0002-7411-1921
  • Llado Plarrumani, Albert|||0000-0002-5066-4150
  • Molinuevo, José Luis|||0000-0003-0485-6001
  • Tainta, Mikel|||0000-0003-0624-1211
  • Clarimón, Jordi|||0000-0002-6824-6942
  • Spires Jones, Tara
  • Blesa, Rafael|||0000-0003-4026-2884
  • Fortea, Juan|||0000-0002-1340-638X
  • Martínez Lage, Pablo
  • Sánchez Valle, Raquel|||0000-0001-7750-896X
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Bayés, Àlex|||0000-0002-5265-6306
  • Belbin, Olivia|||0000-0002-6109-6371
A biomarker of synapse loss, an early event in Alzheimer's disease (AD) pathophysiology that precedes neuronal death and symptom onset, would be a much-needed prognostic biomarker. With direct access to the brain interstitial fluid, the cerebrospinal fluid (CSF) is a potential source of synapse-derived proteins. In this study, we aimed to identify and validate novel CSF biomarkers of synapse loss in AD. Discovery: Combining shotgun proteomics of the CSF with an exhaustive search of the literature and public databases, we identified 251 synaptic proteins, from which we selected 22 for further study. Verification: Twelve proteins were discarded because of poor detection by Selected Reaction Monitoring (SRM). We confirmed the specific expression of 9 of the remaining proteins (Calsyntenin-1, GluR2, GluR4, Neurexin-2A, Neurexin-3A, Neuroligin-2, Syntaxin-1B, Thy-1, Vamp-2) at the human synapse using Array Tomography microscopy and biochemical fractionation methods. Exploration: Using SRM, we monitored these 9 synaptic proteins (20 peptides) in a cohort of CSF from cognitively normal controls and subjects in the pre-clinical and clinical AD stages (n 80). Compared with controls, peptides from 8 proteins were elevated 1.3 to 1.6-fold (p < 0.04) in prodromal AD patients. Validation: Elevated levels of a GluR4 peptide at the prodromal stage were replicated (1.3-fold, p 0.04) in an independent cohort (n 60). Moreover, 7 proteins were reduced at preclinical stage 1 (0.6 to 0.8-fold, p < 0.04), a finding that was replicated (0.7 to 0.8-fold, p < 0.05) for 6 proteins in a third cohort (n 38). In a cross-cohort meta-analysis, 6 synaptic proteins (Calsyn-tenin-1, GluR4, Neurexin-2A, Neurexin-3A, Syntaxin-1B and Thy-1) were reduced 0.8-fold (p < 0.05) in preclinical AD, changes that precede clinical symptoms and CSF markers of neurodegeneration. Therefore, these proteins could have clinical value for assessing disease progression, especially in preclinical stages of AD.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mitochondrial Proteome of Affected Glutamatergic Neurons in a Mouse Model of Leigh Syndrome

  • Gella, Alejandro|||0000-0002-3983-1392
  • Prada Dacasa, Patricia|||0000-0003-0689-9072
  • Carrascal Pérez, Montserrat|||0000-0002-0205-2176
  • Urpi, Andrea|||0000-0002-2437-7094
  • González Torres, Melania|||0000-0002-9755-8160
  • Abian, Joaquin|||0000-0003-2823-5429
  • Sanz Iglesias, Elisenda|||0000-0002-7932-8556
  • Quintana Romero, Albert|||0000-0003-1674-7160
Defects in mitochondrial function lead to severe neuromuscular orphan pathologies known as mitochondrial disease. Among them, Leigh Syndrome is the most common pediatric presentation, characterized by symmetrical brain lesions, hypotonia, motor and respiratory deficits, and premature death. Mitochondrial diseases are characterized by a marked anatomical and cellular specificity. However, the molecular determinants for this susceptibility are currently unknown, hindering the efforts to find an effective treatment. Due to the complex crosstalk between mitochondria and their supporting cell, strategies to assess the underlying alterations in affected cell types in the context of mitochondrial dysfunction are critical. Here, we developed a novel virus-based tool, the AAV-mitoTag viral vector, to isolate mitochondria from genetically defined cell types. Expression of the AAV-mitoTag in the glutamatergic vestibular neurons of a mouse model of Leigh Syndrome lacking the complex I subunit Ndufs4 allowed us to assess the proteome and acetylome of a subset of susceptible neurons in a well characterized model recapitulating the human disease. Our results show a marked reduction of complex I N-module subunit abundance and an increase in the levels of the assembly factor NDUFA2. Transiently associated non-mitochondrial proteins such as PKCδ, and the complement subcomponent C1Q were also increased in Ndufs4 -deficient mitochondria. Furthermore, lack of Ndufs4 induced ATP synthase complex and pyruvate dehydrogenase (PDH) subunit hyperacetylation, leading to decreased PDH activity. We provide novel insight on the pathways involved in mitochondrial disease, which could underlie potential therapeutic approaches for these pathologies.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

SirT7 auto-ADP-ribosylation regulates glucose starvation response through mH2A1

  • Simonet, Nicolas G.|||0000-0001-9921-7645
  • Thackray, Joshua K.|||0000-0003-2828-452X
  • Vazquez Prat, Berta Nieves|||0000-0002-8164-3926
  • Ianni, Alessandro|||0000-0001-7398-589X
  • Espinosa-Alcantud, María Dolores|||0000-0002-1126-2458
  • Morales-Sanfrutos, J.
  • Hurtado-Bagès, Sarah|||0000-0002-6588-0876
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Buschbeck, Marcus|||0000-0002-3218-4567
  • Tischfield, J.
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Esteller, M.|||0000-0003-4490-6093
  • Braun, Thomas|||0000-0002-6165-4804
  • Olivella, Mireia|||0000-0002-6035-3399
  • Serrano, L.
  • Vaquero, Alejandro|||0000-0002-8735-4156
Sirtuins are key players of metabolic stress response. Originally described as deacetylases, some sirtuins also exhibit poorly understood mono-adenosine 5'-diphosphate (ADP)-ribosyltransferase (mADPRT) activity. We report that the deacetylase SirT7 is a dual sirtuin, as it also features auto-mADPRT activity. SirT7 mADPRT occurs at a previously undefined active site, and its abrogation alters SirT7 chromatin distribution. We identify an epigenetic pathway by which ADP-ribosyl-SirT7 is recognized by the ADP-ribose reader mH2A1.1 under glucose starvation, inducing SirT7 relocalization to intergenic regions. SirT7 promotes mH2A1 enrichment in a subset of nearby genes, many of them involved in second messenger signaling, resulting in their specific up- or down-regulation. The expression profile of these genes under calorie restriction is consistently abrogated in SirT7-deficient mice, resulting in impaired activation of autophagy. Our work provides a novel perspective on sirtuin duality and suggests a role for SirT7/mH2A1.1 axis in glucose homeostasis and aging.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cannabis Use Induces Distinctive Proteomic Alterations in Olfactory Neuroepithelial Cells of Schizophrenia Patients

  • Barrera-Conde, Marta|||0000-0002-0106-0000
  • Ausin, Karina|||0000-0003-4914-9466
  • Lachén-Montes, Mercedes
  • Fernández-Irigoyen, Joaquín|||0000-0001-5072-4099
  • Galindo, Liliana|||0000-0002-2396-4772
  • Cuenca-Royo, Aida|||0000-0001-8551-5457
  • Fernández-Avilés, Cristina|||0000-0002-1029-9216
  • Pérez Solà, Víctor|||0000-0002-5825-2337
  • Torre, Rafael de la|||0000-0002-6765-1866
  • Santamaría, Enrique
  • Robledo, Patricia
A close epidemiological link has been reported between cannabis use and schizophrenia (SCZ). However, biochemical markers in living humans related to the impact of cannabis in this disease are still missing. Olfactory neuroepithelium (ON) cells express neural features and offer a unique advantage to study biomarkers of psychiatric diseases. The aim of our study was to find exclusively deregulated proteins in ON cells of SCZ patients with and without a history of cannabis use. Thus, we compared the proteomic profiles of SCZ non-cannabis users (SCZ/nc) and SCZ cannabis users (SCZ/c) with control subjects non-cannabis users (C/nc) and control cannabis users (C/c). The results revealed that the main cascades affected in SCZ/nc were cell cycle, DNA replication, signal transduction and protein localization. Conversely, cannabis use in SCZ patients induced specific alterations in metabolism of RNA and metabolism of proteins. The levels of targeted proteins in each population were then correlated with cognitive performance and clinical scores. In SCZ/c, the expression levels of 2 proteins involved in the metabolism of RNA (MTREX and ZNF326) correlated with several cognitive markers and clinical signs. Moreover, use duration of cannabis negatively correlated with ZNF326 expression. These findings indicate that RNA-related proteins might be relevant to understand the influence of cannabis use on SCZ.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro|||0000-0001-8471-0197
  • Sesé, Marta|||0000-0003-1473-4833
  • Guijarro, Pedro J.
  • Emperador, Marta|||0000-0002-8538-4319
  • Sánchez-Redondo, Sara
  • Peinado, Héctor|||0000-0002-4256-3413
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis. The integrin ITGB3 has been described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. Here the authors describe thus far unknown roles of ITGB3 in the uptake of extracellular vesicles, required for colony growth of breast cancer cells
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Proteomic Studies on the Management of High-Grade Serous Ovarian Cancer Patients, A Mini-Review

  • Bradbury, Melissa|||0000-0003-4974-8899
  • Borràs, Eva|||0000-0002-3859-9907
  • Pérez-Benavente, Assumpció|||0000-0003-1872-9003
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Santamaría Margalef, Anna|||0000-0001-6726-8990
  • Sabidó, Eduard|||0000-0001-6506-7714
In this manuscript, we review the management strategies available for high-grade serous ovarian cancer patients and the molecular advances that are helping improve our understanding of the tumor and its response to treatment. We emphasize the role that proteomics is now playing in the study of ovarian cancer tumors and how its integration with genomics can guide the development of new biomarkers and therapeutic targets. High-grade serous ovarian cancer (HGSC) remains the most common and deadly subtype of ovarian cancer. It is characterized by its late diagnosis and frequent relapse despite standardized treatment with cytoreductive surgery and platinum-based chemotherapy. The past decade has seen significant advances in the clinical management and molecular understanding of HGSC following the publication of the Cancer Genome Atlas (TCGA) researchers and the introduction of targeted therapies with anti-angiogenic drugs and poly(ADP-ribose) polymerase inhibitors in specific subgroups of patients. We provide a comprehensive review of HGSC, focusing on the most important molecular advances aimed at providing a better understanding of the disease and its response to treatment. We emphasize the role that proteomic technologies are now playing in these two aspects of the disease, through the identification of proteins and their post-translational modifications in ovarian cancer tumors. Finally, we highlight how the integration of proteomics with genomics, exemplified by the work performed by the Clinical Proteomic Tumor Analysis Consortium (CPTAC), can guide the development of new biomarkers and therapeutic targets.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BRCA1 mutations in high-grade serous ovarian cancer are associated with proteomic changes in DNA repair, splicing, transcription regulation and signaling

  • Bradbury, Melissa|||0000-0003-4974-8899
  • Castellvi, Josep|||0000-0001-5745-9996
  • Méndez Fernández, Olga|||0000-0003-4237-330X
  • Sánchez Iglesias, José Luis|||0000-0002-4542-3969
  • Pérez-Benavente, Assumpció|||0000-0003-1872-9003
  • Gil-Moreno, Antonio|||0000-0003-1106-5590
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Santamaría Margalef, Anna|||0000-0001-6726-8990
  • Borràs, Eva|||0000-0002-3859-9907
Despite recent advances in the management of BRCA1 mutated high-grade serous ovarian cancer (HGSC), the physiology of these tumors remains poorly understood. Here we provide a comprehensive molecular understanding of the signaling processes that drive HGSC pathogenesis with the addition of valuable ubiquitination profiling, and their dependency on BRCA1 mutation-state directly in patient-derived tissues. Using a multilayered proteomic approach, we show the tight coordination between the ubiquitination and phosphorylation regulatory layers and their role in key cellular processes related to BRCA1-dependent HGSC pathogenesis. In addition, we identify key bridging proteins, kinase activity, and post-translational modifications responsible for molding distinct cancer phenotypes, thus providing new opportunities for therapeutic intervention, and ultimately advance towards a more personalized patient care.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Transcriptome innovations in primates revealed by single-molecule long-read sequencing

  • Ferrández-Peral, Luis|||0000-0003-0338-0603
  • Zhan, Xiaoyu
  • Alvarez-Estape, Marina|||0000-0001-8242-1092
  • Chiva, Cristina
  • Esteller-Cucala, Paula|||0000-0003-3048-4280
  • García Perez, Raquel|||0000-0002-2573-6984
  • Julià, Eva|||0000-0002-9722-4662
  • Lizano, Esther|||0000-0003-3304-9807
  • Fornas, Òscar|||0000-0003-2017-9100
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Li, Qiye
  • Marquès i Bonet, Tomàs|||0000-0002-5597-3075
  • Juan, David|||0000-0003-1912-9667
  • Zhang, Guojie|||0000-0001-6860-1521
Transcriptomic diversity greatly contributes to the fundamentals of disease, lineage-specific biology, and environmental adaptation. However, much of the actual isoform repertoire contributing to shaping primate evolution remains unknown. Here, we combined deep long- and short-read sequencing complemented with mass spectrometry proteomics in a panel of lymphoblastoid cell lines (LCLs) from human, three other great apes, and rhesus macaque, producing the largest full-length isoform catalog in primates to date. Around half of the captured isoforms are not annotated in their reference genomes, significantly expanding the gene models in primates. Furthermore, our comparative analyses unveil hundreds of transcriptomic innovations and isoform usage changes related to immune function and immunological disorders. The confluence of these evolutionary innovations with signals of positive selection and their limited impact in the proteome points to changes in alternative splicing in genes involved in immune response as an important target of recent regulatory divergence in primates.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Malondialdehyde-modified HDL particles elicit a specific IgG response in abdominal aortic aneurysm

  • Rodríguez-Carrio, J.
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Lindholt, Jes S.|||0000-0001-9536-4488
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Martínez-López, Diego
  • Roldán-Montero, R.
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Michel, J.B.
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Suárez, A.
  • Martín-Ventura, J.L.
High Density Lipoprotein (HDL) plays a protective role in abdominal aortic aneurysm (AAA); however, recent findings suggest that oxidative modifications could lead to dysfunctional HDL in AAA. This study aimed at testing the effect of oxidized HDL on aortic lesions and humoral immune responses in a mouse model of AAA induced by elastase, and evaluating whether antibodies against modified HDL can be found in AAA patients. HDL particles were oxidized with malondialdehyde (HDL-MDA) and the changes were studied by biochemical and proteomics approaches. Experimental AAA was induced in mice by elastase perfusion and then mice were treated with HDL-MDA, HDL or vehicle for 14 days. Aortic lesions were studied by histomorphometric analysis. Levels of anti-HDL-MDA IgG antibodies were measured by an in-house immunoassay in the mouse model, in human tissue-supernatants and in plasma samples from the VIVA cohort. HDL oxidation with MDA was confirmed by enhanced susceptibility to diene formation. Proteomics demonstrated the presence of MDA adducts on Lysine residues of HDL proteins, mainly ApoA-I. MDA-modification of HDL abrogated the protective effect of HDL on cultured endothelial cells as well as on AAA dilation in mice. Exposure to HDL-MDA elicited an anti-HDL-MDA IgG response in mice. Anti-HDL-MDA were also detected in tissue-conditioned media from AAA patients, mainly in intraluminal thrombus. Higher plasma levels of anti-HDL-MDA IgG antibodies were found in AAA patients compared to controls. Anti-HDL-MDA levels were associated with smoking and were independent predictors of overall mortality in AAA patients. Overall, MDA-oxidized HDL trigger a specific humoral immune response in mice. Besides, antibodies against HDL-MDA can be detected in tissue and plasma of AAA patients, suggesting its potential use as surrogate stable biomarkers of oxidative stress in AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inhibition of CBP synergizes with the RNA-dependent mechanisms of Azacitidine by limiting protein synthesis

  • Diesch, Jeannine|||0000-0002-4667-3468
  • Le Pannérer, Marguerite Marie|||0000-0002-5779-8805
  • Winkler, René|||0000-0002-7570-0242
  • Casquero, Raquel
  • Muhar, Matthias|||0000-0002-3018-9698
  • van der Garde, Mark
  • Maher, Michael|||0000-0002-4956-7185
  • Martínez Herráez, Carolina|||0000-0003-4711-7225
  • Bech-Serra, Joan-Josep|||0000-0003-3486-781X
  • Fellner, Michaela
  • Rathert, Philipp|||0000-0003-1477-136X
  • Brooks, Nigel
  • Zamora, Lurdes|||0000-0003-1713-7110
  • Gentilella, Antonio|||0000-0002-6830-2086
  • De La Torre Gómez, Gisela Carolina|||0000-0001-9363-291X
  • Zuber, Johannes|||0000-0001-8810-6835
  • Götze, Katharina S.|||0000-0002-6276-8002
  • Buschbeck, Marcus|||0000-0002-3218-4567
The nucleotide analogue azacitidine (AZA) is currently the best treatment option for patients with high-risk myelodysplastic syndromes (MDS). However, only half of treated patients respond and of these almost all eventually relapse. New treatment options are urgently needed to improve the clinical management of these patients. Here, we perform a loss-of-function shRNA screen and identify the histone acetyl transferase and transcriptional co-activator, CREB binding protein (CBP), as a major regulator of AZA sensitivity. Compounds inhibiting the activity of CBP and the closely related p300 synergistically reduce viability of MDS-derived AML cell lines when combined with AZA. Importantly, this effect is specific for the RNA-dependent functions of AZA and not observed with the related compound decitabine that is only incorporated into DNA. The identification of immediate target genes leads us to the unexpected finding that the effect of CBP/p300 inhibition is mediated by globally down regulating protein synthesis.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Role of common cell culture media supplements on citrate-stabilized gold nanoparticle protein corona formation, aggregation state, and the consequent impact on cellular uptake, The Role of common cell culture media supplements on the nanoparticle protein corona formation, aggregation state, and the consequent impact on cellular uptake

  • Barbero, Francesco|||0000-0001-8704-0651
  • Michelini, Sara|||0000-0001-9470-3337
  • Moriones, Oscar Hernando|||0000-0003-0310-0210
  • Patarroyo, Javier|||0000-0002-3703-666X
  • Rosell Aluja, Jordi|||0000-0001-6575-3722
  • Freixanet Gustà, Muriel|||0000-0001-9872-3079
  • Vitali, Michele|||0000-0001-8618-8988
  • Martín, Luna
  • Canals, Francesc|||0000-0002-0650-1135
  • Duschl, Albert|||0000-0002-7034-9860
  • Horejs-Hoeck, Jutta|||0000-0002-0984-204X
  • Mondragón, Laura|||0000-0002-3257-045X
  • Bastús, Neus G.|||0000-0002-3144-7986
  • Puntes, Víctor|||0000-0001-8996-9499
Sodium citrate-stabilized gold nanoparticles (AuNPs) are destabilized when dispersed in cell culture media (CCMs). This may promote their aggregation and subsequent sedimentation, or under the proper conditions, their interaction with dispersed proteins can lead to the formation of a NP-stabilizing protein corona. CCMs are ionic solutions that contain growth substances which are typically supplemented, in addition to serum, with different substances such as dyes, antioxidants, and antibiotics. In this study, the impact of phenol red, penicillin-streptomycin, l-glutamine, and β-mercaptoethanol on the formation of the NP-protein corona in CCMs was investigated. Similar protein coronas were obtained except in the presence of antibiotics. Under these conditions, the protein corona took more time to be formed, and its density and composition were altered, as indicated by UV-vis spectroscopy, Z potential, dynamic light scattering, and liquid chromatography-mass spectrometry analyses. As a consequence of these modifications, a significantly different AuNP cellular uptake was measured, showing that NP uptake increased as did the NP aggregate formation. AuNP uptake studies performed in the presence of clathrin- and caveolin-mediated endocytosis inhibitors showed that neither clathrin receptors nor lipid rafts were significantly involved in the internalization mechanism. These results suggest that in these conditions, NP aggregation is the main mechanism responsible for their cellular uptake.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Multi-ancestry genome-wide association study of asthma exacerbations

  • Herrera-Luis, Esther|||0000-0003-4150-5454
  • Ortega, Victor E.
  • Ampleford, Elizabeth J.
  • Sio, Yang Yie
  • Granell, Raquel|||0000-0002-4890-4012
  • de Roos, Emmely
  • Terzikhan, Natalie
  • Vergara, Ernesto Elorduy
  • Hernandez-Pacheco, Natalia
  • Perez-Garcia, Javier|||0000-0001-7813-4381
  • Martin-Gonzalez, Elena
  • Lorenzo-Diaz, Fabian
  • Hashimoto, Simone|||0000-0001-8995-3817
  • Brinkman, Paul
  • Jorgensen, Andrea L.
  • Yan, Qi|||0000-0002-5236-9673
  • Forno, Erick|||0000-0001-6497-9885
  • Vijverberg, Susanne J.
  • Lethem, Ryan
  • Espuela-Ortiz, Antonio|||0000-0003-0572-9549
  • Gorenjak, Mario|||0000-0003-4208-9683
  • Eng, Celeste
  • González-Pérez, Ruperto
  • Hernández-Pérez, José M.|||0000-0002-2920-212X
  • Poza-Guedes, Paloma
  • Sardón, Olaia
  • Corcuera, Paula|||0000-0001-8661-7033
  • Hawkins, Greg A.
  • Marsico, Annalisa
  • Bahmer, Thomas
  • Rabe, Klaus F.|||0000-0002-7020-1401
  • Hansen, Gesine
  • Kopp, Matthias V.
  • Rios, Raimon
  • Cruz, María Jesús|||0000-0001-9759-5466
  • González-Barcala, Francisco Javier
  • Olaguibel, José María
  • Plaza, Vicente|||0000-0003-2567-5496
  • Quirce Gancedo, Santiago|||0000-0001-8086-0921
  • Canino, Glorisa
  • Cloutier, Michelle|||0000-0001-8316-6409
  • Del Pozo, Victoria|||0000-0001-6228-1969
  • Rodriguez-Santana, Jose R.
  • Korta-Murua, Javier
  • Villar, Jesús
  • Potočnik, Uros
  • Figueiredo, Camila|||0000-0003-1356-6188
  • Kabesch, Michael
  • Mukhopadhyay, Somnath
  • Pirmohamed, Munir|||0000-0002-7534-7266
  • Hawcutt, Daniel
  • Melén, Erik|||0000-0002-8248-0663
  • Palmer, Colin|||0000-0002-6415-6560
  • Turner, Steve|||0000-0001-8393-5060
  • Maitland-van der Zee, Anke H.
  • von Mutius, Erika
  • Celedón, Juan C.|||0000-0002-6139-5320
  • Brusselle, Guy|||0000-0001-7021-8505
  • Chew, Fook Tim|||0000-0003-1337-5146
  • Bleecker, Eugene
  • Meyers, Deborah
  • Burchard, Esteban G.
  • Pino-Yanes, Maria
Background: Asthma exacerbations are a serious public health concern due to high healthcare resource utilization, work/school productivity loss, impact on quality of life, and risk of mortality. The genetic basis of asthma exacerbations has been studied in several populations, but no prior study has performed a multi-ancestry meta-analysis of genome-wide association studies (meta-GWAS) for this trait. We aimed to identify common genetic loci associated with asthma exacerbations across diverse populations and to assess their functional role in regulating DNA methylation and gene expression. Methods: A meta-GWAS of asthma exacerbations in 4989 Europeans, 2181 Hispanics/Latinos, 1250 Singaporean Chinese, and 972 African Americans analyzed 9.6 million genetic variants. Suggestively associated variants (p ≤ 5 × 10) were assessed for replication in 36,477 European and 1078 non-European asthma patients. Functional effects on DNA methylation were assessed in 595 Hispanic/Latino and African American asthma patients and in publicly available databases. The effect on gene expression was evaluated in silico. Results: One hundred and twenty-six independent variants were suggestively associated with asthma exacerbations in the discovery phase. Two variants independently replicated: rs12091010 located at vascular cell adhesion molecule-1/exostosin like glycosyltransferase-2 (VCAM1/EXTL2) (discovery: odds ratio (OR) = 0.82, p = 9.05 × 10 and replication: OR = 0.89, p = 5.35 × 10) and rs943126 from pantothenate kinase 1 (PANK1) (discovery: OR = 0.85, p = 3.10 × 10 and replication: OR = 0.89, p = 1.30 × 10). Both variants regulate gene expression of genes where they locate and DNA methylation levels of nearby genes in whole blood. Conclusions: This multi-ancestry study revealed novel suggestive regulatory loci for asthma exacerbations located in genomic regions participating in inflammation and host defense.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Alpha-1 antitrypsin deficiency and Pi*S and Pi*Z SERPINA1 variants are associated with asthma exacerbations

  • Martín-González, Elena|||0000-0002-3522-3103
  • Hernández-Pérez, José M.|||0000-0002-2920-212X
  • Pérez Pérez, José A.
  • Perez-Garcia, Javier|||0000-0001-7813-4381
  • Herrera-Luis, Esther|||0000-0003-4150-5454
  • González-Pérez, Ruperto
  • González-González, Orelvis
  • Mederos-Luis, Elena
  • Sánchez Machín, Inmaculada|||0000-0003-0109-8735
  • Poza-Guedes, Paloma
  • Sardón, Olaia
  • Corcuera, Paula|||0000-0001-8661-7033
  • Cruz, María Jesús|||0000-0001-9759-5466
  • González-Barcala, Francisco-Javier|||0000-0001-5847-4784
  • Martínez Rivera, Carlos|||0000-0003-1031-2561
  • Mullol, Joaquim|||0000-0003-3463-5007
  • Muñoz Gall, Francisco Javier|||0000-0002-8693-022X
  • Olaguibel, José M.
  • Plaza, Vicente|||0000-0003-2567-5496
  • Quirce Gancedo, Santiago|||0000-0001-8086-0921
  • Valero, Antonio
  • Sastre, Joaquin|||0000-0003-4689-6837
  • Korta-Murua, Javier
  • Del Pozo, Victoria|||0000-0001-6228-1969
  • Lorenzo-Díaz, Fabián
  • Villar, Jesús
  • Pino-Yanes, María|||0000-0003-0332-437X
  • González-Carracedo, M.A.|||0000-0003-1386-0571
Introduction and objectives: Asthma is a chronic inflammatory disease of the airways. Asthma patients may experience potentially life-threatening episodic flare-ups, known as exacerbations, which may significantly contribute to the asthma burden. The Pi*S and Pi*Z variants of the SERPINA1 gene, which usually involve alpha-1 antitrypsin (AAT) deficiency, had previously been associated with asthma. The link between AAT deficiency and asthma might be represented by the elastase/antielastase imbalance. However, their role in asthma exacerbations remains unknown. Our objective was to assess whether SERPINA1 genetic variants and reduced AAT protein levels are associated with asthma exacerbations. Materials and methods: In the discovery analysis, SERPINA1 Pi*S and Pi*Z variants and serum AAT levels were analyzed in 369 subjects from La Palma (Canary Islands, Spain). As replication, genomic data from two studies focused on 525 Spaniards and publicly available data from UK Biobank, FinnGen, and GWAS Catalog (Open Targets Genetics) were analyzed. The associations between SERPINA1 Pi*S and Pi*Z variants and AAT deficiency with asthma exacerbations were analyzed with logistic regression models, including age, sex, and genotype principal components as covariates. Results: In the discovery, a significant association with asthma exacerbations was found for both Pi*S (odds ratio [OR]=2.38, 95% confidence interval [CI]= 1.40-4.04, p-value=0.001) and Pi*Z (OR=3.49, 95%CI=1.55-7.85, p-value=0.003)Likewise, AAT deficiency was associated with a higher risk for asthma exacerbations (OR=5.18, 95%CI=1.58-16.92, p-value=0.007) as well as AAT protein levels (OR= 0.72, 95%CI=0.57-0.91, p-value=0.005). The Pi*Z association with exacerbations was replicated in samples from Spaniards with two generations of Canary Islander origin (OR=3.79, p-value=0.028), and a significant association with asthma hospitalizations was found in the Finnish population (OR=1.12, p-value=0.007). Conclusions: AAT deficiency could be a potential therapeutic target for asthma exacerbations in specific populations.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Short- and medium-term air pollution exposure, plasmatic protein levels and blood pressure in children

  • Prado Bert, Paula de|||0000-0003-1901-5846
  • Warembourg, Charline|||0000-0003-2716-9167
  • Dedele, Audrius
  • Heude, Barbara
  • Borràs, Eva|||0000-0002-3859-9907
  • Sabidó, Eduard|||0000-0001-6506-7714
  • Aasvang, Gunn Marit
  • Lepeule, Johanna|||0000-0001-8907-197X
  • Wright, John|||0000-0001-9572-7293
  • Urquiza, Jose|||0000-0003-2220-607X
  • Gützkow, Kristine B.
  • Maitre, Léa|||0000-0003-3682-7117
  • Chatzi, Leda
  • Casas, Maribel
  • Vafeiadi, Marina
  • Nieuwenhuijsen, Mark|||0000-0001-9461-7981
  • de Castro, Montserrat
  • Grazuleviciene, Regina|||0000-0002-0210-8053
  • McEachan, Rosemary R.C.
  • Basagaña, X.|||0000-0002-8457-1489
  • Vrijheid, Martine|||0000-0002-7090-1758
  • Sunyer, Jordi
  • Bustamante, Mariona|||0000-0003-0127-2860
Exposure to air pollution influences children's health, however, the biological mechanisms underlying these effects are not completely elucidated. We investigated the association between short- and medium-term outdoor air pollution exposure with protein profiles and their link with blood pressure in 1170 HELIX children aged 6-11 years. Different air pollutants (NO2, PM10, PM2.5, and PM2.5abs) were estimated based on residential and school addresses at three different windows of exposure (1-day, 1-week, and 1-year before clinical and molecular assessment). Thirty-six proteins, including adipokines, cytokines, or apolipoproteins, were measured in children's plasma using Luminex. Systolic and diastolic blood pressure (SBP and DBP) were measured following a standardized protocol. We performed an association study for each air pollutant at each location and time window and each outcome, adjusting for potential confounders. After correcting for multiple-testing, hepatocyte growth factor (HGF) and interleukin 8 (IL8) levels were positively associated with 1-week home exposure to some of the pollutants (NO2, PM10, or PM2.5). NO2 1-week home exposure was also related to higher SBP. The mediation study suggested that HGF could explain 19% of the short-term effect of NO2 on blood pressure, but other study designs are needed to prove the causal directionality between HGF and blood pressure.